Automotive Camera is projected to grow at a CAGR of 13.94% during the forecast period 2020-2025.

The automobile industry maintains a very strong presence and value, considering the fact that many major corporations have challenges with overcapacity and low profitability. The sector also has decent benefits for well-paid workers, has close ties with producers (which gives it an oversized position in economic development), and has a strong political impact.

Many new vehicles have autonomous systems, such as autonomous emergency braking (AEB). AEB systems use radar, cameras, and lidar technologies to determine the road ahead and figure out possible accidents. In general, these devices warn the driver that action is required to avert a potential collision, and then, if no action is taken, the AEB will be activated on the driver's behalf. The use of tiny cameras in the vehicle makes it easier for the driver to search for concealed items that are normally impossible for the driver to see from the driving seat. There are tire pressure sensors to avoid collisions, lane shift sensors, and crash control sensors. The use of an anti-lock brake mechanism and stability control both allow drivers to keep their vehicles under control while driving.

The rise in demand for autonomous vehicles and the increasing adoption of driving assistance features have played a pivotal role in the adoption of automotive cameras globally. Along with this, the increase in the disposable income of individuals has resulted in the demand for luxury vehicles. ADAS and park assist features, among others, have been installed widely in these vehicles, thus providing an impetus for growth to the automotive camera market.

The automotive camera market was estimated at $6,304.2 Million in 2019 and is projected to grow at a CAGR of 13.94% during the forecast period 2020-2025.

Trends influencing the automotive camera include growing popularity of stereo vision cameras, next-generation 3d surround view systems, integrating cameras into headlight and taillights, and combining cameras and other sensors for early detection of aquaplaning situations.

The market research study offers a wide perspective of different automotive cameras used in vehicles. The report also provides an analysis of the market penetration of cameras in different applications and their growth opportunities across different regions as well as countries. The study focuses on the changing landscape of the automotive camera market, owing to the significant developments made by the leading players.

Market Segmentation

• Application Type – Passenger and Commercial

• By Type – Front View, Side View, Rear View, and In-vehicle Cameras

• Technology – Infrared and Digital

• View Type- Single View and Multi View

• Level of Autonomy- Level 1, Level 2, Level 3, Level 4, and Level 5

Regional Segmentation

• North America - U.S., Canada, and Mexico

• Europe – Germany, Spain, France, and Rest-of-Europe

• Asia-Pacific and Japan (APJ) - South Korea, India, Japan, and Rest-of-APJ

• U.K.

• China

• Rest-of-the-World

Growth Drivers

• Regulations and Mandates Appreciating the Usage of Automotive Cameras

• Growing Popularity of Autonomous Vehicles

• Prevention of False Insurance Claims

• Increasing Road Accidents

Market Challenges

• Lapses in Imagery Sensors and Difficulty in Detection

• High Cost of Camera Modules

Market Opportunities

• AI-Based In-Vehicle Cameras for Advanced Driver Monitoring

• Integrating Camera and Lidar into a Single Unit

Key Companies Profiled

Ficosa International S.A., Continental AG, Denso Corporation, Hella KGaA Hueck & Co., OmniVision Technologies, Inc., Stonkam Co., Ltd., Hyundai Mobis Co. Ltd., Kappa optronics GmbH, Magna International Inc., Ricoh Company Ltd., Robert Bosch GmbH, STMicroelectronics N.V., Valeo Group, LG Innotek Co., Ltd., and Aptiv PLC

Request a Sample- https://bisresearch.com/requestsample?id=1056&type=download

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Lung Cancer Genomic Testing Market Industry Structure, Development, Demographics, Demands, Main Players, Innovative Technologies, and Opportunities Till 2031

The shift of healthcare systems toward precision diagnostic and precision medicine will drive the adoption of lung cancer genomic testing facilitating informed treatment decision making and improving healthcare outcomes. Increasing recommendations by the international oncology societies for the use of genomic testing for lung cancer diagnosis provides major opportunities in the global lung cancer genomic testing market. The lung cancer genomic testing medicine market was valued at $1,262.0 million in 2020 and is expected to reach $3,279.8 million by 2031, growing at a CAGR of 8.97% during the forecast period 2021-2031. The growth in the global lung cancer genomic testing market is expected to be driven by increasing awareness and adoption of the lung cancer genomic testing market, recent launches of novel lung cancer genomic testing, and the expanding research in the field of lung cancer with an emphasis on pharmacogenomics and development of companion diagnostics. Im...

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global ligase market is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development. Impact Several techniques are employed in ...

Market Research Reports

Search This Blog